Safety of Intensive Chelation Therapy
- 13 January 1977
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 296 (2) , 114
- https://doi.org/10.1056/nejm197701132960229
Abstract
To the Editor: Propper, Shurin and Nathan1 have reported that continuous intravenous administration of desferrioxamine results in very efficient removal of iron. Others have made similar observations.2 , 3 Recent use of a portable infusion pump has made continuous administration practical by the subcutaneous route. When oral ascorbic acid is given simultaneously,1 2 3 4 up to 100 mg of iron per day may be excreted. The observations have brought expanded use of these drugs, particularly for patients who already have clinical manifestations of iron overload. Unfortunately, seven deaths have recently occurred among patients who received desferrioxamine and ascorbic acid. A meeting was held . . .Keywords
This publication has 4 references indexed in Scilit:
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*Annals of the New York Academy of Sciences, 1974
- Cardiac Involvement in Cooley's AnemiaAnnals of the New York Academy of Sciences, 1964